Please Wait.....
Report
North America and Europe Women's Health Market - Industry Trends and Forecast to 2031
Market Report I 2024-02-01 I 295 Pages I Data Bridge Market Research
Europe women's health market is expected to reach USD 5,384.03 million by 2031, from USD 3,280.54 million in 2023 growing at the CAGR of 6.7% in the forecast period of 2024 to 2031.
North America women's health market is expected to reach USD 11,108.64 million by 2031 from USD 5,841.61 million in 2023, growing at a CAGR of 9.3% in the forecast period of 2024 to 2031.
Market Segmentation
North America and Europe Women's Health Market, By Treatment (Drugs and Devices), Indication (Cancer, Reproductive Health, Urological Disorders, Hypothyroidism, Post-Menopausal Syndrome, and Others), Delivery Mode (Prescription and Over The Counter), Drug Type (Branded and Generic), Care Type (General Healthcare & Wellness, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, and Others), End User (Hospitals and Clinics, Gynecology Centers, Homecare Settings, Homecare Setting, Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, Online Sales, and Others), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, Hungary, and Rest of Europe) - Industry Trends and Forecast to 2031
Overview of Europe Women's Health Market Dynamics
Driver
- Rising rates of chronic debilitating conditions among women
Restrain
- Adverse effects associated with certain products
Opportunity
- Growing awareness and acceptance of fertility treatments
Market Players
Some of the major players operating in the North America and Europe women's health market are:
- Pfizer Inc.
- Lilly
- Novartis AG
- AbbVie Inc.
- GSK plc.
- Abbott
- Noven Pharmaceuticals, Inc.
- Lupin
- Vertical Pharmaceuticals, LLC
- Veru Inc.
TABLE OF CONTENTS
1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 OVERVIEW OF NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET 31
1.4 CURRENCY AND PRICING 33
1.5 LIMITATIONS 33
1.6 MARKETS COVERED 33
2 MARKET SEGMENTATION 37
2.1 MARKETS COVERED 37
2.2 GEOGRAPHICAL SCOPE 38
2.3 YEARS CONSIDERED FOR THE STUDY 39
2.4 DBMR TRIPOD DATA VALIDATION MODEL 40
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.6 MULTIVARIATE MODELLING 45
2.7 MARKET APPLICATION COVERAGE GRID 46
2.8 PRODUCT LIFELINE CURVE 47
2.9 DBMR MARKET POSITION GRID 48
2.10 VENDOR SHARE ANALYSIS 50
2.11 SECONDARY SOURCES 51
2.12 ASSUMPTIONS 51
3 EXECUTIVE SUMMARY 52
4 PREMIUM INSIGHTS 55
4.1 PESTEL ANALYSIS 57
4.2 PORTER'S FIVE FORCES 58
4.3 INDUSTRY INSIGHTS 59
4.3.1 DRUG TREATMENT RATE IN MATURED MARKETS 59
4.3.2 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 59
4.3.3 PATIENT FLOW DIAGRAMS 59
4.3.4 KEY PRICING STRATEGIES 60
4.3.5 KEY ENROLLMENT STRATEGIES 60
4.4 PIPELINE ANALYSIS 63
4.5 PATENT DATA ANALYSIS 67
5 MARKET OVERVIEW 71
5.1 DRIVERS 73
5.1.1 RISING RATES OF CHRONIC DEBILITATING CONDITIONS AMONG WOMEN 73
5.1.2 INNOVATIVE TECHNOLOGIES BEING DEVELOPED AS AN AFTERMATH OF R&D ACTIVITIES 73
5.1.3 GOVERNMENT INITIATIVES TO IMPROVE OVERALL HEALTH AND WELLBEING 74
5.1.4 CHANGING LIFESTYLES AND ENVIRONMENTAL FACTORS IMPACTING HEALTH 75
5.2 RESTRAINTS 76
5.2.1 ADVERSE EFFECTS ASSOCIATED WITH CERTAIN PRODUCTS 76
5.2.2 STRICT REGULATIONS IMPOSED BY THE REGULATORY AGENCIES 76
5.3 OPPORTUNITIES 77
5.3.1 INCREASING RECOGNITION FOR MENTAL HEALTH 77
5.3.2 GROWING AWARENESS AND ACCEPTANCE OF FERTILITY TREATMENTS 78
5.3.3 GROWING INCIDENCES OF SEXUALLY TRANSMITTED DISEASES 79
5.4 CHALLENGES 80
5.4.1 ENVIRONMENTAL EXPOSURE IMPACTING REPRODUCTIVE HEALTH 80
5.4.2 HIGH MATERNAL MORTALITY AND MORBIDITY 81
6 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY TREATMENT 82
6.1 OVERVIEW 83
6.2 DRUGS 89
6.3 DEVICE 98
7 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY INDICATION 100
7.1 OVERVIEW 101
7.2 CANCER 108
7.3 REPRODUCTIVE HEALTH 109
7.4 UROLOGICAL DISORDERS 110
7.5 HYPOTHYROIDISM 110
7.6 POST-MENOPAUSAL SYNDROME 110
7.7 OTHERS 111
8 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY CARE TYPE 112
8.1 OVERVIEW 113
8.2 GENERAL HEALTHCARE & WELLNESS 120
8.3 PREGNANCY & NURSING CARE 121
8.4 PELVIC & UTERINE HEALTHCARE 122
8.5 OTHERS 122
9 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY DRUG TYPE 123
9.1 OVERVIEW 124
9.2 BRANDED 130
9.3 GENERIC 130?
10 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY DELIVERY MODE 131
10.1 OVERVIEW 132
10.2 PRESCRIPTION 138
10.3 OVER THE COUNTER 138
11 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY END USER 139
11.1 OVERVIEW 140
11.2 HOSPITALS AND CLINICS 146
11.3 GYNECOLOGY CENTERS 146
11.4 HOMECARE SETTING 147
11.5 RESEARCH INSTITUTES 147
11.6 OTHERS 147
12 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY DISTRIBUTION CHANNEL 148
12.1 OVERVIEW 149
12.2 DIRECT TENDERS 155
12.3 RETAIL SALES 155
12.4 ONLINE SALES 155
12.5 OTHERS 156
13 NORTH AMERICA AND EUROPE WOMEN'S HEALTH MARKET, BY REGION 157
13.1 NORTH AMERICA 157
13.1.1 U.S. 160
13.1.2 CANADA 169
13.1.3 MEXICO 177
13.2 EUROPE 185
13.2.1 GERMANY 188
13.2.2 FRANCE 196
13.2.3 U.K. 205
13.2.4 ITALY 213
13.2.5 RUSSIA 221
13.2.6 SPAIN 229
13.2.7 TURKEY 237
13.2.8 NETHERLANDS 245
13.2.9 SWITZERLAND 253
13.2.10 BELGIUM 261
13.2.11 REST OF EUROPE 269?
14 NORTH AMERICA AND EUROPE WOMEN HEALTH MARKET: COMPANY LANDSCAPE 270
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 270
14.2 COMPANY SHARE ANALYSIS: EUROPE 271
15 SWOT ANALYSIS 272
16 COMPANY PROFILE 273
16.1 ABBOTT 273
16.1.1 COMPANY SNAPSHOT 273
16.1.2 REVENUE ANALYSIS 273
16.1.3 PRODUCT PORTFOLIO 274
16.1.4 RECENT DEVELOPMENT 274
16.2 ABBVIE INC. 275
16.2.1 COMPANY SNAPSHOT 275
16.2.2 REVENUE ANALYSIS 275
16.2.3 PRODUCT PORTFOLIO 276
16.2.4 RECENT DEVELOPMENT 276
16.3 GSK PLC. 277
16.3.1 COMPANY SNAPSHOT 277
16.3.2 REVENUE ANALYSIS 277
16.3.3 PRODUCT PORTFOLIO 278
16.3.4 RECENT DEVELOPMENT 278
16.4 LILLY 279
16.4.1 COMPANY SNAPSHOT 279
16.4.2 REVENUE ANALYSIS 279
16.4.3 PRODUCT PORTFOLIO 280
16.4.4 RECENT DEVELOPMENT 280
16.5 LUPIN 281
16.5.1 COMPANY SNAPSHOT 281
16.5.2 REVENUE ANALYSIS 281
16.5.3 PRODUCT PORTFOLIO 282
16.5.4 RECENT DEVELOPMENT 282
16.6 NOVARTIS AG 283
16.6.1 COMPANY SNAPSHOT 283
16.6.2 REVENUE ANALYSIS 283
16.6.3 PRODUCT PORTFOLIO 284
16.6.4 RECENT DEVELOPMENT 284?
16.7 NOVEN PHARMACEUTICALS, INC. 285
16.7.1 COMPANY SNAPSHOT 285
16.7.2 PRODUCT PORTFOLIO 285
16.7.3 RECENT DEVELOPMENT 286
16.8 PFIZER INC. 287
16.8.1 COMPANY SNAPSHOT 287
16.8.2 REVENUE ANALYSIS 287
16.8.3 PRODUCT PORTFOLIO 288
16.8.4 RECENT DEVELOPMENT 288
16.9 VERTICAL PHARMACEUTICALS, LLC 289
16.9.1 COMPANY SNAPSHOT 289
16.9.2 PRODUCT PORTFOLIO 289
16.9.3 RECENT DEVELOPMENT 289
16.10 VERU INC. 290
16.10.1 COMPANY SNAPSHOT 290
16.10.2 REVENUE ANALYSIS 290
16.10.3 PRODUCT PORTFOLIO 291
16.10.4 RECENT DEVELOPMENT 291
17 QUESTIONNAIRE 292
18 RELATED REPORTS 295
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security